CANY
CNMD icon

Caxton Associates (New York)’s CONMED CNMD Stock Holding History

Caxton Associates (New York)’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,943
Closed -$396K – 477
2022
Q3 		$396K Buy
4,943
+2,306
+87% +$218K 0.05% 280
2022
Q2 		$253K Buy
+2,637
New +$316K 0.02% 421

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Caxton Associates (New York)'s CNMD Position: Q4 2022 in Review

Caxton Associates (New York) sold out of CONMED (CNMD) in Q4 2022, closing a stake of 4,943 shares — an estimated $396K sold.

Caxton Associates (New York) first reported a position in CNMD in Q2 2022 and held it in 2 quarters. The position peaked at $396K in Q3 2022. 239 funds tracked by Wall St. Rank hold CNMD as of Q4 2022.

  • Caxton Associates (New York) reported no remaining CONMED position as of Q4 2022 after selling out during the quarter.
  • Caxton Associates (New York) sold 4,943 CONMED shares in Q4 2022, an estimated $396K.
  • Caxton Associates (New York) first reported a position in CONMED in Q2 2022 and held it in 2 quarters.
  • Caxton Associates (New York)'s CONMED position peaked at $396K in Q3 2022.
  • 239 funds tracked by Wall St. Rank held CONMED as of Q4 2022.

Based on Caxton Associates (New York)'s 13F filing for Q4 2022, filed 14 Feb 2023.